Comment from Laboratorios Farmacéuticos ROVI, S.A.
AnonymousOtherIndividual
In section 2 is mentioned "quality issues" but this term is not described in the document nor FDA regulation. Could be possible to define it? Also, are quality issues expected to be reported to FDA?